ライフサイエンスコーパス: gestational hypertension

1 omen with preeclampsia, including those with gestational hypertension.

2 preterm preeclampsia, term preeclampsia, and gestational hypertension.

3 cholesterol levels and 2) family history of gestational hypertension.

4 fore and after the onset of preeclampsia and gestational hypertension.

5 diabetes treatment also reduced the risk for gestational hypertension.

6 risk for preeclampsia and decreased risk for gestational hypertension.

7 th term preeclampsia and not associated with gestational hypertension.

8 nly baseline BP and BMI were associated with gestational hypertension.

9 taining multivitamins may reduce the risk of gestational hypertension.

10 ation between folic acid supplementation and gestational hypertension.

11 ere: pre-eclampsia, 1.78 (95% CI 1.52-2.08); gestational hypertension 1.76 (1.39-2.23); gestational d

12 rated a significantly decreased incidence of gestational hypertension (1.6% versus 8.5%; P < 0.01), b

13 at term (at > or =37 weeks), 120 women with gestational hypertension, 120 normotensive women who del

14 ed miscarriage (13.3%), preeclampsia (4.4%), gestational hypertension (4.4%), proteinuria (4.4%), and

15 Common associated conditions were gestational hypertension (43%), tocolytic therapy (19%),

16 ore common among donors (odds ratio, 2.5 for gestational hypertension and 2.4 for preeclampsia).

17 underlie epidemiologic associations between gestational hypertension and a higher risk of hypertensi

18 preterm premature rupture of the membranes, gestational hypertension and gestational diabetes.

19 ive disorders of pregnancy (HDPs), including gestational hypertension and pre-eclampsia, are common o

20 idney donation seems to elevate the risks of gestational hypertension and pre-eclampsia.

21 women, and to be even greater in women with gestational hypertension and preeclampsia at term.

22 The risks of gestational hypertension and preeclampsia were compared

23 ntify women who are at an increased risk for gestational hypertension and preeclampsia.

24 reuptake inhibitors (SSRIs) on the risks of gestational hypertension and preeclampsia.

25 protective against preeclampsia without pre gestational hypertension, and even then principally amon

26 Pre-eclampsia, gestational hypertension, and small-for-gestational-age

27 Preeclampsia and gestational hypertension are leading complications of pr

28 iated with reduced rates of preeclampsia and gestational hypertension (combined rates for the two con

29 ilatation was higher during a pregnancy with gestational hypertension compared with preeclampsia (P=0

30 Gestational hypertension develops differently, with a hy

31 variate-adjusted relative risk of developing gestational hypertension during the month after folic ac

32 HDP for ischemic stroke, late menopause and gestational hypertension for hemorrhagic stroke, and oop

33 hocardiography in pregnancies complicated by gestational hypertension (GH) and preeclampsia.

34 nsion in the general population, but data on gestational hypertension (GH) are limited.

35 n of gestational diabetes mellitus (GDM) and gestational hypertension (GH) with cardiometabolic disea

36 ny hypertensive disorder in pregnancy (HDP) (gestational hypertension [GH], preeclampsia, or eclampsi

37 was to compare the risk of preeclampsia and gestational hypertension in a prospective cohort of norm

38 on risk of de novo preeclampsia (n = 44) and gestational hypertension (n = 172) among women recruited

39 (n=1,180), mild preeclampsia (n=5,468), and gestational hypertension (n=8,943).

40 7 person-years of follow-up among women with gestational hypertension, n = 40 cardiomyopathy events;

41 tation who had nonproteinuric preexisting or gestational hypertension, office diastolic blood pressur

42 Of 2,100 women, 204 (9.7%) reported gestational hypertension (onset after the 20th week of g

43 ies in donors may incur attributable risk of gestational hypertension or preeclampsia (11% versus 5%

44 Gestational hypertension or preeclampsia was more common

45 Gestational hypertension or preeclampsia was more likely

46 primary outcome was a hospital diagnosis of gestational hypertension or preeclampsia.

47 .06-1.27), but they were not associated with gestational hypertension (OR, 1.07; 95% CI, 0.92-1.25).

48 preeclampsia (OR=1.5, 95% CI: 1.3, 1.8), and gestational hypertension (OR=1.4, 95% CI: 1.2, 1.6).

49 women who later developed term preeclampsia, gestational hypertension, or normotensive pregnancy.

50 Preterm birth combined with hemorrhage, gestational hypertension, or preexisting hypertension id

51 m preeclampsia: OR, 0.98; 95% CI, 0.88-1.10; gestational hypertension: OR, 1.13; 95% CI, 0.92-1.38).

52 Hypertensive disorders (gestational hypertension, preeclampsia, chronic hyperten

53 regnancy (severe or moderate preeclampsia or gestational hypertension) registered in the National Pat

54 .3; P = 0.01), while their relative risk for gestational hypertension remained significantly decrease

55 Analyses of gestational hypertension showed no indication of a prote

56 4% in both mild preeclamptics and those with gestational hypertension) than in controls (2.7%).

57 Gestational hypertension was associated with increased r

58 Gestational hypertension was defined as incident hyperte

59 Among women who received treatment, gestational hypertension was present in 13.1% of the 107

60 Gestational hypertension was present in 9.0% of the 5,53

61 Gestational hypertension was related to heart failure (a

62 ious pregnancy, but not term preeclampsia or gestational hypertension, was associated with offspring

63 There was strong evidence of a high risk of gestational hypertension with deflation compared with co

64 Some evidence of a higher risk of gestational hypertension with deflation than with inflat

65 point was pre-eclampsia, which we defined as gestational hypertension with proteinuria.